Genetic abnormalities in benign or malignant tissues predict relapse of prostate cancer
While active monitoring of serum prostate specific antigen (PSA) levels in men over 50 has greatly improved early detection of prostate cancer, prediction of clinical outcomes after diagnosis remains a major challenge. Researchers ...
May 7, 2012
0
0